MetLife (NYSE:MET – Get Free Report) had its price target dropped by stock analysts at Wells Fargo & Company from $97.00 to $93.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the financial services provider’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 23.85% from the stock’s previous close.
Other equities analysts also recently issued research reports about the company. Evercore set a $95.00 price target on MetLife in a research report on Tuesday, February 10th. Weiss Ratings raised shares of MetLife from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday. Barclays set a $90.00 price objective on shares of MetLife in a research report on Thursday, January 8th. Mizuho set a $100.00 target price on shares of MetLife in a research report on Thursday, February 12th. Finally, Morgan Stanley set a $101.00 target price on shares of MetLife and gave the stock an “overweight” rating in a research note on Monday, December 15th. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $94.91.
Check Out Our Latest Report on MetLife
MetLife Stock Performance
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company had revenue of $52.44 billion during the quarter, compared to analysts’ expectations of $31.43 billion. During the same quarter in the previous year, the company earned $2.08 earnings per share. The firm’s revenue for the quarter was up 27.6% on a year-over-year basis. As a group, research analysts anticipate that MetLife will post 9.65 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. MidFirst Bank purchased a new stake in shares of MetLife during the 4th quarter valued at approximately $425,000. SG Trading Solutions LLC purchased a new stake in MetLife during the fourth quarter worth about $217,000. Kera Capital Partners Inc. purchased a new stake in MetLife during the 4th quarter worth approximately $232,000. MV Capital Management Inc. acquired a new stake in MetLife during the 4th quarter worth approximately $487,000. Finally, Wick Capital Partners LLC purchased a new position in MetLife in the 4th quarter valued at approximately $212,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Further Reading
- Five stocks we like better than MetLife
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
